Literature DB >> 31499711

CSB modulates the competition between HIF-1 and p53 upon hypoxia.

Xiao-Wei Ye1, Xiao-Peng Zhang2,3, Feng Liu1,3.   

Abstract

Both hypoxia-inducible factor-1 (HIF-1) and tumor suppressor p53 are involved in the cellular response to hypoxia. It has been reported that HIF-1α induces cockayne syndrome B (CSB) to compete with p53 for limited p300. We developed a network model to clarify how the interplay between HIF-1 and p53 modulates cellular output in the presence of CSB. Our results revealed that HIF-1α is progressively activated depending on the severity of hypoxia. Activated HIF-1α promotes its own activation by inducing CSB to dissociate p300 from p53 under moderate hypoxia; in severe hypoxia, p53 accumulates remarkably due to ATR-dependent phosphorylation and wins the competition for p300. As a result, HIF-1α induces PFKL and VEGF to facilitate cellular adaptation to mild and moderate hypoxia respectively, while p53 is activated to induce apoptosis under severe hypoxia. This work may advance the understanding of the modulation of the interplay between HIF-1 and p53 in the hypoxic response.

Entities:  

Keywords:  p53; CSB; HIF-1α; hypoxia; network model

Mesh:

Substances:

Year:  2019        PMID: 31499711     DOI: 10.3934/mbe.2019262

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  2 in total

1.  Different p53 genotypes regulating different phosphorylation sites and subcellular location of CDC25C associated with the formation of polyploid giant cancer cells.

Authors:  Kai Liu; Minying Zheng; Qi Zhao; Kexin Zhang; Zugui Li; Fangmei Fu; Hao Zhang; Jiaxing Du; Yuwei Li; Shiwu Zhang
Journal:  J Exp Clin Cancer Res       Date:  2020-05-11

2.  Immunohistochemical study of STAT3, HIF-1α and VEGF in pterygium and normal conjunctiva: Experimental research and literature review.

Authors:  Shiqi Dong; Xiying Wu; Yuting Xu; Guohua Yang; Ming Yan
Journal:  Mol Vis       Date:  2020-07-26       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.